- Country: Poland
- Summary: Successive Delivery of a Medicinal Product Containing the Active Substance of Niwuwumab Along with the Labeling, Release and Transport Process to 8 Centers in Poland
- PLT Ref No: 70863095
- Deadline: 12 Sep 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 465076-2022
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Document Type: Corigendum/Additional Information (Please Depder Tender Document)
Title: Successive delivery of a medicinal product containing the active substance of niwuwumab along with the labeling, release and transport process to 8 centers in Poland
Reference number: gum2022zp0082
Contract Type: Supplies
Description: The subject of the contract is the successive delivery of a medicinal product, containing the active substance of the niwolumab along with the process of labeling, release and transporting the drug to 8 centers as part of the implementation of non -commercial clinical examination: "Use of nivolumab (n) with subsequent chemotherapy: Bendamustina, Gemcitabine and dexamethasone (BGD) with autologous bone marrow transplantation in patients with hodgkin -resistant lymphoma patients ("Nivolumab Followed by Bendamustine, Gemcitabine and Dexamethasone Chemotherapy (BGD) and autologous hematopoietic cell transplantation in patients - 2020 ABM/01/00103 as part of the Medical Research Agency competition (ABM) for research and development activities in the field of non-commercial clinical trials. The Gdańsk Medical University is full of ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSuccessive Delivery of a Medicinal Product Containing the Active Substance of Niwuwumab Along with the Labeling, Release and Transport Process to 8 Centers in Poland - Poland Tender
The GDAŃSK MEDICAL UNIVERSITY, a Government sector organization in Poland, has announced a new tender for Successive Delivery of a Medicinal Product Containing the Active Substance of Niwuwumab Along with the Labeling, Release and Transport Process to 8 Centers in Poland. This tender is published on PolandTenders under PLT Ref No: 70863095 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-09-12.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
